Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
8.17
+0.05 (0.62%)
At close: May 14, 2025, 4:00 PM
8.12
-0.05 (-0.61%)
After-hours: May 14, 2025, 7:43 PM EDT
Anavex Life Sciences Employees
Anavex Life Sciences had 42 employees as of September 30, 2024. The number of employees increased by 2 or 5.00% compared to the previous year.
Employees
42
Change (1Y)
2
Growth (1Y)
5.00%
Revenue / Employee
n/a
Profits / Employee
-$1,122,405
Market Cap
697.49M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AVXL News
- 17 hours ago - Anavex Life Sciences to Participate at Upcoming Healthcare Conferences - GlobeNewsWire
- 1 day ago - Anavex Life Sciences Corp. (AVXL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 8 days ago - Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025 - GlobeNewsWire
- 13 days ago - Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia - GlobeNewsWire
- 14 days ago - Anavex Life Sciences to Participate in The Citizens Life Sciences Conference - GlobeNewsWire
- 21 days ago - Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board - GlobeNewsWire
- 23 days ago - Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer's Disease and Related Disorders in the Middle East - GlobeNewsWire